Literature DB >> 19575028

Structure and signalling in the IL-17 receptor family.

Sarah L Gaffen1.   

Abstract

Interleukin-17A (IL-17A), the hallmark cytokine of the newly defined T helper 17 (T(H)17) cell subset, has important roles in protecting the host against extracellular pathogens, but also promotes inflammatory pathology in autoimmune disease. IL-17A and its receptor (IL-17RA) are the founding members of a newly described family of cytokines and receptors that have unique structural features which distinguish them from other cytokine families. Research defining the signal transduction pathways induced by IL-17R family cytokines has lagged behind that of other cytokine families, but studies in the past 2 years have begun to delineate unusual functional motifs and new proximal signalling mediators used by the IL-17R family to mediate downstream events.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19575028      PMCID: PMC2821718          DOI: 10.1038/nri2586

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  109 in total

Review 1.  The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation.

Authors:  Kristine Kikly; Ling Liu; Songqing Na; Jonathon D Sedgwick
Journal:  Curr Opin Immunol       Date:  2006-09-28       Impact factor: 7.486

Review 2.  The IL-17 cytokine family.

Authors:  Sarah L Gaffen; Jill M Kramer; Jeffrey J Yu; Fang Shen
Journal:  Vitam Horm       Date:  2006       Impact factor: 3.421

3.  A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.

Authors:  Richard H Duerr; Kent D Taylor; Steven R Brant; John D Rioux; Mark S Silverberg; Mark J Daly; A Hillary Steinhart; Clara Abraham; Miguel Regueiro; Anne Griffiths; Themistocles Dassopoulos; Alain Bitton; Huiying Yang; Stephan Targan; Lisa Wu Datta; Emily O Kistner; L Philip Schumm; Annette T Lee; Peter K Gregersen; M Michael Barmada; Jerome I Rotter; Dan L Nicolae; Judy H Cho
Journal:  Science       Date:  2006-10-26       Impact factor: 47.728

4.  The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease.

Authors:  Youcun Qian; Caini Liu; Justin Hartupee; Cengiz Zubeyir Altuntas; Muhammet Fatih Gulen; Daniel Jane-Wit; Jianhua Xiao; Yi Lu; Natalia Giltiay; Jinbo Liu; Tomasz Kordula; Qi-Wei Zhang; Bruce Vallance; Shadi Swaidani; Mark Aronica; Vincent K Tuohy; Thomas Hamilton; Xiaoxia Li
Journal:  Nat Immunol       Date:  2007-02-04       Impact factor: 25.606

5.  Generation of interleukin-17 receptor-like protein (IL-17RL) in prostate by alternative splicing of RNA.

Authors:  Dominik R Haudenschild; Shane B Curtiss; Timothy A Moseley; A Hari Reddi
Journal:  Prostate       Date:  2006-09-01       Impact factor: 4.104

6.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

Authors:  Ivaylo I Ivanov; Brent S McKenzie; Liang Zhou; Carlos E Tadokoro; Alice Lepelley; Juan J Lafaille; Daniel J Cua; Dan R Littman
Journal:  Cell       Date:  2006-09-22       Impact factor: 41.582

7.  Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor.

Authors:  Seon Hee Chang; Heon Park; Chen Dong
Journal:  J Biol Chem       Date:  2006-10-11       Impact factor: 5.157

8.  Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells.

Authors:  Jill F Wright; Yongjing Guo; Amira Quazi; Deborah P Luxenberg; Frann Bennett; John F Ross; Yongchang Qiu; Matthew J Whitters; Kathleen N Tomkinson; Kyri Dunussi-Joannopoulos; Beatriz M Carreno; Mary Collins; Neil M Wolfman
Journal:  J Biol Chem       Date:  2007-03-13       Impact factor: 5.157

Review 9.  A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage.

Authors:  Lawrence Steinman
Journal:  Nat Med       Date:  2007-02       Impact factor: 53.440

10.  Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides.

Authors:  Spencer C Liang; Xiang-Yang Tan; Deborah P Luxenberg; Riyez Karim; Kyriaki Dunussi-Joannopoulos; Mary Collins; Lynette A Fouser
Journal:  J Exp Med       Date:  2006-09-18       Impact factor: 14.307

View more
  546 in total

Review 1.  Th17 cells in depression.

Authors:  Eléonore Beurel; Jeffrey A Lowell
Journal:  Brain Behav Immun       Date:  2017-08-03       Impact factor: 7.217

2.  Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection.

Authors:  Sarah E Hardison; Karen L Wozniak; Jay K Kolls; Floyd L Wormley
Journal:  Infect Immun       Date:  2010-10-04       Impact factor: 3.441

3.  Clinical associations between IL-17 family cytokines and periodontitis and potential differential roles for IL-17A and IL-17E in periodontal immunity.

Authors:  Raja Azman Awang; Raja Azman; David F Lappin; Alexandrea MacPherson; Marcello Riggio; Douglas Robertson; Penny Hodge; Gordon Ramage; Shauna Culshaw; Philip M Preshaw; John Taylor; Christopher Nile
Journal:  Inflamm Res       Date:  2014-11-05       Impact factor: 4.575

Review 4.  Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity.

Authors:  Peter J Morrison; Sarah J Ballantyne; Marika C Kullberg
Journal:  Immunology       Date:  2011-06-02       Impact factor: 7.397

5.  Macrophages participate in IL-17-mediated inflammation.

Authors:  Jobert G Barin; G Christian Baldeviano; Monica V Talor; Lei Wu; Sufey Ong; Farhan Quader; Ping Chen; Dongfeng Zheng; Patrizio Caturegli; Noel R Rose; Daniela Ciháková
Journal:  Eur J Immunol       Date:  2012-01-23       Impact factor: 5.532

6.  The expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas.

Authors:  Lubin Qiu; Dongsheng He; Xiang Fan; Zhi Li; Chuangxin Liao; Yonghong Zhu; Haijun Wang
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

7.  TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms.

Authors:  Sergey V Novitskiy; Michael W Pickup; Agnieszka E Gorska; Philip Owens; Anna Chytil; Mary Aakre; Huiyun Wu; Yu Shyr; Harold L Moses
Journal:  Cancer Discov       Date:  2011-10       Impact factor: 39.397

Review 8.  A tale of two cytokines: IL-17 and IL-22 in asthma and infection.

Authors:  Michelle L Manni; Keven M Robinson; John F Alcorn
Journal:  Expert Rev Respir Med       Date:  2013-12-10       Impact factor: 3.772

9.  HSP90 inhibitor geldanamycin reverts IL-13- and IL-17-induced airway goblet cell metaplasia.

Authors:  Alejandro A Pezzulo; Rosarie A Tudas; Carley G Stewart; Luis G Vargas Buonfiglio; Brian D Lindsay; Peter J Taft; Nicholas D Gansemer; Joseph Zabner
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

10.  Unexpected kidney-restricted role for IL-17 receptor signaling in defense against systemic Candida albicans infection.

Authors:  Kritika Ramani; Chetan V Jawale; Akash H Verma; Bianca M Coleman; Jay K Kolls; Partha S Biswas
Journal:  JCI Insight       Date:  2018-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.